Pharmaceutical Glass Packaging Market Size, Share and Growth Report (2025-2030)

Table of Contents

1. Executive Summary
   1. Introduction
2. Market Introduction
   1. Market Definition
   2. Scope of the Study
   3. Market Structure
3. Research Methodology
   1. Primary Research
   2. Research Methodology
   3. Assumptions & Exclusions
   4. Secondary Data Sources
4. Market Factor Analysis
   1. Value Chain Analysis: Pharmaceutical Glass Packaging Market
   2. Porters Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitution
      4. Threat of New Entrants
      5. Competitive Rivalry
5. Market Dynamics
   1. Drivers
   2. Restraints
   3. Opportunities
6. Recent Trends Analysis
7. Impact of COVID-19 on Pharmaceutical Glass Packaging Market
   1. Pre and Post Covid -19 Market Scenario Analysis
   2. Market Recovery Timeline and Challenge
   3. Measures Taken by Top Players
8. Regulatory Landscape
9. Pharmaceutical Glass Packaging Market, By Product Type
   1. Introduction
      1. Market Size and Forecast, By Product Type
   2. Vials
      1. Market Size and Forecast, By Region
   3. Ampoules
      1. Market Size and Forecast, By Region
   4. Bottles
      1. Market Size and Forecast, By Region
   5. Cartridges
      1. Market Size and Forecast, By Region
   6. Syringes
      1. Market Size and Forecast, By Region
10. Pharmaceutical Glass Packaging Market, By Glass Type
    1. Introduction
       1. Market Size and Forecast, By Glass Type
    2. Type I (Borosilicate Glass)
       1. Market Size and Forecast, By Region
    3. Type II (Treated Soda-Lime Glass)
       1. Market Size and Forecast, By Region
    4. Type III (Soda-Lime Glass)
       1. Market Size and Forecast, By Region
11. Pharmaceutical Glass Packaging Market, By Drug Type
    1. Introduction
       1. Market Size and Forecast, By Drug Type
    2. Injectable Drugs
       1. Market Size and Forecast, By Region
    3. Oral Liquid Drugs
       1. Market Size and Forecast, By Region
    4. Biologics & Biosimilars
       1. Market Size and Forecast, By Region
12. Pharmaceutical Glass Packaging Market, By End Use
    1. Introduction
       1. Market Size and Forecast, By End Use
    2. Pharmaceutical Manufacturers
       1. Market Size and Forecast, By Region
    3. Contract Manufacturing Organizations
       1. Market Size and Forecast, By Region
13. Regional Overview
    1. Introduction
       1. Market Size and Forecast
    2. North America
       1. Market Size and Forecast
          1. By Product Type
             1. Vials
             2. Ampoules
             3. Bottles
             4. Cartridges
             5. Syringes
          2. By Glass Type
             1. Type I (Borosilicate Glass)
             2. Type II (Treated Soda-Lime Glass)
             3. Type III (Soda-Lime Glass)
          3. By Drug Type
             1. Injectable Drugs
             2. Oral Liquid Drugs
             3. Biologics & Biosimilars
          4. By End Use
             1. Pharmaceutical Manufacturers
             2. Contract Manufacturing Organizations
       2. U.S.
          1. By Product Type
             1. Vials
             2. Ampoules
             3. Bottles
             4. Cartridges
             5. Syringes
          2. By Glass Type
             1. Type I (Borosilicate Glass)
             2. Type II (Treated Soda-Lime Glass)
             3. Type III (Soda-Lime Glass)
          3. By Drug Type
             1. Injectable Drugs
             2. Oral Liquid Drugs
             3. Biologics & Biosimilars
          4. By End Use
             1. Pharmaceutical Manufacturers
             2. Contract Manufacturing Organizations
       3. Canada
    3. Europe
       1. Market Size and Forecast
          1. By Product Type
             1. Vials
             2. Ampoules
             3. Bottles
             4. Cartridges
             5. Syringes
          2. By Glass Type
             1. Type I (Borosilicate Glass)
             2. Type II (Treated Soda-Lime Glass)
             3. Type III (Soda-Lime Glass)
          3. By Drug Type
             1. Injectable Drugs
             2. Oral Liquid Drugs
             3. Biologics & Biosimilars
          4. By End Use
             1. Pharmaceutical Manufacturers
             2. Contract Manufacturing Organizations
       2. U.K.
          1. By Product Type
             1. Vials
             2. Ampoules
             3. Bottles
             4. Cartridges
             5. Syringes
          2. By Glass Type
             1. Type I (Borosilicate Glass)
             2. Type II (Treated Soda-Lime Glass)
             3. Type III (Soda-Lime Glass)
          3. By Drug Type
             1. Injectable Drugs
             2. Oral Liquid Drugs
             3. Biologics & Biosimilars
          4. By End Use
             1. Pharmaceutical Manufacturers
             2. Contract Manufacturing Organizations
       3. Germany
       4. France
       5. Spain
       6. Italy
       7. Russia
       8. Nordic
       9. Benelux
       10. Rest of Europe
    4. APAC
       1. Market Size and Forecast
          1. By Product Type
             1. Vials
             2. Ampoules
             3. Bottles
             4. Cartridges
             5. Syringes
          2. By Glass Type
             1. Type I (Borosilicate Glass)
             2. Type II (Treated Soda-Lime Glass)
             3. Type III (Soda-Lime Glass)
          3. By Drug Type
             1. Injectable Drugs
             2. Oral Liquid Drugs
             3. Biologics & Biosimilars
          4. By End Use
             1. Pharmaceutical Manufacturers
             2. Contract Manufacturing Organizations
       2. China
          1. By Product Type
             1. Vials
             2. Ampoules
             3. Bottles
             4. Cartridges
             5. Syringes
          2. By Glass Type
             1. Type I (Borosilicate Glass)
             2. Type II (Treated Soda-Lime Glass)
             3. Type III (Soda-Lime Glass)
          3. By Drug Type
             1. Injectable Drugs
             2. Oral Liquid Drugs
             3. Biologics & Biosimilars
          4. By End Use
             1. Pharmaceutical Manufacturers
             2. Contract Manufacturing Organizations
       3. South Korea
       4. Japan
       5. India
       6. Australia
       7. Singapore
       8. Taiwan
       9. South East Asia
       10. Rest of Asia-Pacific
    5. Middle East and Africa
       1. Market Size and Forecast
          1. By Product Type
             1. Vials
             2. Ampoules
             3. Bottles
             4. Cartridges
             5. Syringes
          2. By Glass Type
             1. Type I (Borosilicate Glass)
             2. Type II (Treated Soda-Lime Glass)
             3. Type III (Soda-Lime Glass)
          3. By Drug Type
             1. Injectable Drugs
             2. Oral Liquid Drugs
             3. Biologics & Biosimilars
          4. By End Use
             1. Pharmaceutical Manufacturers
             2. Contract Manufacturing Organizations
       2. UAE
          1. By Product Type
             1. Vials
             2. Ampoules
             3. Bottles
             4. Cartridges
             5. Syringes
          2. By Glass Type
             1. Type I (Borosilicate Glass)
             2. Type II (Treated Soda-Lime Glass)
             3. Type III (Soda-Lime Glass)
          3. By Drug Type
             1. Injectable Drugs
             2. Oral Liquid Drugs
             3. Biologics & Biosimilars
          4. By End Use
             1. Pharmaceutical Manufacturers
             2. Contract Manufacturing Organizations
       3. Turky
       4. Saudi Arabia
       5. South Africa
       6. Egypt
       7. Nigeria
       8. Rest of MEA
    6. LATAM
       1. Market Size and Forecast
          1. By Product Type
             1. Vials
             2. Ampoules
             3. Bottles
             4. Cartridges
             5. Syringes
          2. By Glass Type
             1. Type I (Borosilicate Glass)
             2. Type II (Treated Soda-Lime Glass)
             3. Type III (Soda-Lime Glass)
          3. By Drug Type
             1. Injectable Drugs
             2. Oral Liquid Drugs
             3. Biologics & Biosimilars
          4. By End Use
             1. Pharmaceutical Manufacturers
             2. Contract Manufacturing Organizations
       2. Brazil
          1. By Product Type
             1. Vials
             2. Ampoules
             3. Bottles
             4. Cartridges
             5. Syringes
          2. By Glass Type
             1. Type I (Borosilicate Glass)
             2. Type II (Treated Soda-Lime Glass)
             3. Type III (Soda-Lime Glass)
          3. By Drug Type
             1. Injectable Drugs
             2. Oral Liquid Drugs
             3. Biologics & Biosimilars
          4. By End Use
             1. Pharmaceutical Manufacturers
             2. Contract Manufacturing Organizations
       3. Mexico
       4. Argentina
       5. Chile
       6. Colombia
       7. Rest of LATAM
14. Competitive Landscape, 2025
    1. Introduction
    2. Pharmaceutical Glass Packaging Market Share Analysis, 2025 (%)
       1. Market Share Analysis, 2025
       2. Competition Ranking, 2025
       3. Key Developments & Growth Strategies
          1. Merger & Acquisition
          2. Product Launch
          3. Expansion
       4. Consolidated SWOT Analysis of Key Players
15. Company Profile
    1. SCHOTT AG
       1. Business Overview
       2. Financial Data
       3. Key Product domains
       4. Recent Developments
    2. Gerresheimer AG
    3. Corning Incorporated
    4. SGD Pharma
    5. Nipro Corporation
    6. Stevanato Group
    7. Ardagh Group
    8. West Pharmaceutical Services
    9. Piramal Glass
    10. Ompi S.p.A.
    11. Bormioli Pharma
    12. DWK Life Sciences
    13. Shandong Pharmaceutical Glass Co., Ltd.
    14. Stoelzle Glass Group
    15. Beatson Clark